NO954805D0 - Anxiolytisk middel - Google Patents

Anxiolytisk middel

Info

Publication number
NO954805D0
NO954805D0 NO954805A NO954805A NO954805D0 NO 954805 D0 NO954805 D0 NO 954805D0 NO 954805 A NO954805 A NO 954805A NO 954805 A NO954805 A NO 954805A NO 954805 D0 NO954805 D0 NO 954805D0
Authority
NO
Norway
Prior art keywords
anxiolytic agent
chem
excluded
hydroxy
represent
Prior art date
Application number
NO954805A
Other languages
English (en)
Other versions
NO954805L (no
NO309506B1 (no
Inventor
Junji Yamamoto
Takashi Arima
Nobuo Kasahara
Masato Nanri
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of NO954805D0 publication Critical patent/NO954805D0/no
Publication of NO954805L publication Critical patent/NO954805L/no
Publication of NO309506B1 publication Critical patent/NO309506B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Fats And Perfumes (AREA)
  • Glass Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO954805A 1994-03-28 1995-11-27 Anxiolytisk middel, bisyklolaktamforbindelse og anvendelse av nye og kjente bisyklolaktamforbindelser NO309506B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8393494 1994-03-28
PCT/JP1995/000575 WO1995026187A1 (en) 1994-03-28 1995-03-28 Anxiolytic agent

Publications (3)

Publication Number Publication Date
NO954805D0 true NO954805D0 (no) 1995-11-27
NO954805L NO954805L (no) 1996-01-29
NO309506B1 NO309506B1 (no) 2001-02-12

Family

ID=13816431

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954805A NO309506B1 (no) 1994-03-28 1995-11-27 Anxiolytisk middel, bisyklolaktamforbindelse og anvendelse av nye og kjente bisyklolaktamforbindelser

Country Status (13)

Country Link
EP (1) EP0713702B1 (no)
KR (1) KR0168508B1 (no)
AT (1) ATE277614T1 (no)
AU (1) AU702454B2 (no)
CA (1) CA2163216C (no)
DE (1) DE69533573T2 (no)
DK (1) DK0713702T3 (no)
ES (1) ES2230546T3 (no)
FI (1) FI955728A0 (no)
HU (2) HU218479B (no)
NO (1) NO309506B1 (no)
PT (1) PT713702E (no)
WO (1) WO1995026187A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004975A (en) * 1994-03-28 1999-12-21 Taiho Pharmaceutical Company Limited Bicyclolactam compounds, use thereof and intermediates for preparing thereof
US6159987A (en) * 1994-03-28 2000-12-12 Taiho Pharmaceuticals, Co. Bicyclolactam compounds, use thereof and intermediates for preparing thereof
JP3161948B2 (ja) * 1995-06-12 2001-04-25 大鵬薬品工業株式会社 ビシクロラクタム化合物
US6575908B2 (en) 1996-06-28 2003-06-10 Sonosite, Inc. Balance body ultrasound system
US7135484B2 (en) 2002-08-14 2006-11-14 Abbott Laboratories Azabicyclic compounds are central nervous system active agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2083568T3 (es) * 1990-02-02 1996-04-16 Taiho Pharmaceutical Co Ltd Derivado de biciclolactama.

Also Published As

Publication number Publication date
PT713702E (pt) 2005-01-31
WO1995026187A1 (en) 1995-10-05
HU9503388D0 (en) 1996-02-28
HU221727B1 (hu) 2002-12-28
EP0713702A1 (en) 1996-05-29
FI955728A (fi) 1995-11-28
KR960702307A (ko) 1996-04-27
NO954805L (no) 1996-01-29
HUT75124A (en) 1997-04-28
HU218479B (hu) 2000-09-28
CA2163216A1 (en) 1995-10-05
CA2163216C (en) 1999-08-31
EP0713702B1 (en) 2004-09-29
KR0168508B1 (ko) 1999-01-15
ES2230546T3 (es) 2005-05-01
HU9904686D0 (en) 2000-03-28
DE69533573D1 (de) 2004-11-04
DK0713702T3 (da) 2004-12-06
AU702454B2 (en) 1999-02-25
FI955728A0 (fi) 1995-11-28
EP0713702A4 (en) 1997-11-19
AU2083695A (en) 1995-10-17
DE69533573T2 (de) 2006-02-23
NO309506B1 (no) 2001-02-12
ATE277614T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
AU678814B2 (en) Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
AU5082790A (en) Triazine derivative and herbicide containing the same as active ingredient
MX9300222A (es) Nuevos derivados de arilcicloalquilo, su preparacion y su utilizacion.
DE69511424D1 (de) Antifungale sordaridinderivate
ES2161713T3 (es) Derivado de metotrexato.
AU2623192A (en) Antifungal agent
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
DE69312776T2 (de) Fungizide 3,4-Diaryl-(5H)-Furan-2-Onederivate
DK0713702T3 (da) Anxiolytisk middel
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
ATE127806T1 (de) Antibiotikverbindungen und ihre herstellung.
ATE163005T1 (de) Saintopin derivate
ES2117992T3 (es) Derivados de pirazina.
DE69422038T2 (de) Benzopyranderivate